Last Verified: | June/30/2014 |
First Submitted: | November/18/2008 |
Estimated Enrollment Submitted: | November/18/2008 |
First Posted: | November/19/2008 |
Last Update Submitted: | July/6/2014 |
Last Update Posted: | July/7/2014 |
Actual Study Start Date: | August/31/2009 |
Estimated Primary Completion Date: | September/30/2013 |
Estimated Study Completion Date: | September/30/2013 |
Study Type: | Interventional |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Masking: | Double (Participant, Investigator) |
Arm | Intervention/treatment |
---|---|
Experimental: 1 Association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. | Drug: 1 1 tablet PO twice a day |
Active Comparator: 2 Valeriana officinalis 50 mg | Drug: 2 1 tablet PO twice a day |
Ages Eligible for Study: | 18 Years to 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria: | Inclusion Criteria: - generalized anxiety disorder - HAM-A scale < 17 and > 30 Exclusion Criteria: - hypersensibility to any component - patients with depression, schizophrenia ou suicidal ideas - pregnant ou lactating - heart, liver, lung or kidney important condition - use of digitalis, AAS, anticoagulants agents, drugs with sedative or antidepressant action - psychotherapy - drug or alcohol dependence - gastrointestinal ulcer history - hyperthyroidism - neoplasia - coagulation disorders |